Hypoxia-induced CXC chemokine ligand 14 expression drives protumorigenic effects through activation of insulin-like growth factor-1 receptor signaling in glioblastoma.

Wei, Sung-Tai; Chiang, Jung-Ying; Wang, Hwai-Lee; Lei, Fu-Ju; Huang, Yen-Chih; Wang, Chi-Chung; Cho, Der-Yang; Hsieh, Chia-Hung

Wei, Sung-Tai; Chiang, Jung-Ying; Wang, Hwai-Lee; Lei, Fu-Ju; Huang, Yen-Chih; Wang, Chi-Chung; Cho, Der-Yang; Hsieh, Chia-Hung.

Afiliação

Wei ST; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Chiang JY; Division of Neurosurgery, Department of Surgery, An Nan Hospital, China Medical University, Tainan, Taiwan.
Wang HL; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Lei FJ; Department of Neurosurgery, China Medical University Hsinchu Hospital, Hsinchu, Taiwan.
Huang YC; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Wang CC; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Cho DY; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Hsieh CH; Department of Medical Imaging, China Medical University and Hospital, Taichung, Taiwan.

Cancer Sci ; 114(1): 174-186, 2023 Jan.

Article em En | MEDLINE | ID: mdl-36106406

Assuntos

Glioblastoma; Humanos; Glioblastoma/metabolismo; Quimiocinas CXC/genética; Fator de Crescimento Insulin-Like I; Ligantes; Hipóxia; Transdução de Sinais; RNA Interferente Pequeno; Linhagem Celular Tumoral; Microambiente Tumoral

Palavras-chave

CXC chemokine ligand 14; glioblastoma; hypoxia-inducible factor; nanoparticle; tumor hypoxia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma Limite: Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google